On July 22, 2021, the "Academic Conference on Lung Cancer Markers Helping Surgery Patients' Whole Process Management" sponsored by Chengdu High-tech Medical Association was successfully held online. This academic conference was held to promote the early detection, prevention and diagnosis of the disease , Monitoring innovative, cost-effective, timely and reliable diagnostic systems and solutions, thereby helping medical staff to improve the treatment effect of patients, improve people's quality of life, and reduce social medical costs.

This academic forum invited clinical-related experts from inside and outside the province to participate in special academic reports, and discuss and exchange relevant professional classic cases and cutting-edge technologies. The conference was opened by Professor Li Qiang from Sichuan Cancer Hospital as the chairman. Professor Wang Pu from the First Affiliated Hospital of Chongqing Medical University made an in-depth analysis on the topic of "Lung Cancer Serum Tumor Markers Helping Management of Lung Nodules"; Nanchong Central Hospital Professor Luo Hui made a case sharing; on the topic of "How to dynamically monitor tumor markers for preoperative and postoperative follow-up, so as to optimize the whole process management", the guests started an encouraging academic discussion.

The meeting was summarized by Professor Li Qiang. Professor Li said that biomarkers generally refer to a certain characteristic biochemical index in ordinary physiology or pathology or treatment process that can be objectively measured and evaluated. The process in the biological process. Checking a disease-specific biomarker may be helpful for disease identification, early diagnosis and prevention, and monitoring during treatment. Therefore, the convening of this academic conference has strong practicability, progress and maneuverability, and can also help medical staff to further improve the relevant technical level and understand the new developments and new developments related to lung cancer markers.